Provided by Tiger Trade Technology Pte. Ltd.

Anebulo Pharmaceuticals, Inc.

0.5005
-0.3207-39.05%
Post-market: 0.5001-0.0004-0.08%19:49 EST
Volume:793.18K
Turnover:414.33K
Market Cap:20.56M
PE:-2.23
High:0.6600
Open:0.4401
Low:0.4351
Close:0.8212
52wk High:3.42
52wk Low:0.4351
Shares:41.08M
Float Shares:3.40M
Volume Ratio:8.42
T/O Rate:23.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2245
EPS(LYR):-0.2509
ROE:-145.11%
ROA:-86.11%
PB:2.11
PE(LYR):-2.00

Loading ...

Anebulo Pharmaceuticals Announces Voluntary Nasdaq Delisting Plan

TIPRANKS
·
Feb 06

BRIEF-Anebulo Pharmaceuticals Announces Intention To Voluntarily Delist From Nasdaq And Deregister With SEC

Reuters
·
Feb 06

Anebulo Pharmaceuticals Announces Intention to Voluntarily Delist From Nasdaq and Deregister With SEC

THOMSON REUTERS
·
Feb 06

Anebulo Pharmaceuticals - Stock to Trade Privately & on Otc Market Post-Delisting

THOMSON REUTERS
·
Feb 06

Anebulo Pharmaceuticals Buys Back 300,000 Shares at $3.50 Each for $1.05 Million

Reuters
·
Jan 29

Anebulo Pharmaceuticals Buys Back 300,000 Shares for $1.05 Million

Reuters
·
Jan 27

Anebulo Pharmaceuticals Announces Oversubscribed Self-Tender Offer Results

TIPRANKS
·
Jan 27

Anebulo Pharmaceuticals Announces Preliminary Results of Tender Offer

THOMSON REUTERS
·
Jan 27

Anebulo Pharmaceuticals Launches Self Tender Offer to Buy Back 300,000 Shares at $3.50 Each for $1,050,000 USD

Reuters
·
Dec 22, 2025

Anebulo Pharmaceuticals Announces Its Intent to Commence a Self Tender Offer

THOMSON REUTERS
·
Dec 22, 2025

Anebulo Pharmaceuticals Inc - to Buy up to 300,000 Shares at $3.50 per Share

THOMSON REUTERS
·
Dec 22, 2025

Anebulo Pharmaceuticals Q1 EPS $(0.05) Beats $(0.12) Estimate

Benzinga
·
Nov 14, 2025

Anebulo Pharmaceuticals posts Q1 net loss

Reuters
·
Nov 14, 2025

Anebulo Pharmaceuticals Board Approves Reverse Stock Split

Reuters
·
Nov 14, 2025

Anebulo Pharmaceuticals reports first quarter net loss of $0.05 per share

Reuters
·
Nov 14, 2025

Anebulo Pharmaceuticals reports Q1 EPS (5c), one estimate (12c)

TIPRANKS
·
Nov 14, 2025

Anebulo Pharmaceuticals, Inc. Q1 EPS USD -0.05

THOMSON REUTERS
·
Nov 14, 2025

Press Release: Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2026 Financial Results and Recent Updates

Dow Jones
·
Nov 14, 2025

Anebulo Pharmaceuticals Inc expected to post a loss of 12 cents a share - Earnings Preview

Reuters
·
Nov 08, 2025

Anebulo Pharmaceuticals’ Bold Move: Potential Risks of Going Private with Reverse Stock Split

TIPRANKS
·
Oct 02, 2025